Resultado de búsqueda
13 de may. de 2024 · Corporate Overview. 22nd Century Group, Inc. is a leading plant biotechnology company focused on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp/cannabis plants through genetic engineering, gene-editing, and modern plant breeding.
Hace 1 día · XXII. -12,90%. MOCKSVILLE, NC - 22nd Century Group, Inc. (NASDAQ: XXII), empresa especializada en la reducción de daños causados por el tabaco y la nicotina, ha anunciado hoy que John Miller ...
15 de may. de 2024 · 22nd Century Group Reports First Quarter 2024 Financial Results. New Contracts to Boost Second Quarter Revenue. Reduced Operating Costs, Improved Cash Position. Reduced ~$8.0 Million of Outstanding Debt and Liabilities for Equity Exchanges in Q2 2024.
24 de may. de 2024 · 22nd Century Group, Inc. operates as a plant bio technology company. The Company focuses on technologies nicotine in tobacco plants and level of cannabinoids in hemp cannabis plants through...
- 198
24 de may. de 2024 · Stock quote information. Pricing delayed by 20 minutes. Last Updated 05/24/2024 3:59 PM. Price. $1.24. Volume. 95,011. Change. -0.01.
15 de may. de 2024 · Mocksville, North Carolina-- (Newsfile Corp. - May 15, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction, today reported results...
15 de may. de 2024 · 22nd Century Group, Inc. (NASDAQ: XXII) is an agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science.
